227 related articles for article (PubMed ID: 30850252)
1. Impact of syndrome-specific antimicrobial stewardship interventions on use of and resistance to fluoroquinolones: An interrupted time series analysis.
Hecker MT; Son AH; Murphy NN; Sethi AK; Wilson BM; Watkins RR; Donskey CJ
Am J Infect Control; 2019 Aug; 47(8):869-875. PubMed ID: 30850252
[TBL] [Abstract][Full Text] [Related]
2. Effects of fluoroquinolone restriction (from 2007 to 2012) on Clostridium difficile infections: interrupted time-series analysis.
Sarma JB; Marshall B; Cleeve V; Tate D; Oswald T; Woolfrey S
J Hosp Infect; 2015 Sep; 91(1):74-80. PubMed ID: 26169793
[TBL] [Abstract][Full Text] [Related]
3. Effect of a national 4C antibiotic stewardship intervention on the clinical and molecular epidemiology of Clostridium difficile infections in a region of Scotland: a non-linear time-series analysis.
Lawes T; Lopez-Lozano JM; Nebot CA; Macartney G; Subbarao-Sharma R; Wares KD; Sinclair C; Gould IM
Lancet Infect Dis; 2017 Feb; 17(2):194-206. PubMed ID: 27825595
[TBL] [Abstract][Full Text] [Related]
4. Effect of a Health Care System Respiratory Fluoroquinolone Restriction Program To Alter Utilization and Impact Rates of Clostridium difficile Infection.
Shea KM; Hobbs ALV; Jaso TC; Bissett JD; Cruz CM; Douglass ET; Garey KW
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28348151
[TBL] [Abstract][Full Text] [Related]
5. Reducing Fluoroquinolone Use and Clostridioides difficile Infections in Community Nursing Homes Through Hospital-Nursing Home Collaboration.
Felsen CB; Dodds Ashley ES; Barney GR; Nelson DL; Nicholas JA; Yang H; Aydelotte ME; Karlic A; Nicholas NC; Petrone KK; Pine RD; Schabel SL; Medina-Walpole A; Dumyati GK
J Am Med Dir Assoc; 2020 Jan; 21(1):55-61.e2. PubMed ID: 31888865
[TBL] [Abstract][Full Text] [Related]
6. Changes in resistance among coliform bacteraemia associated with a primary care antimicrobial stewardship intervention: A population-based interrupted time series study.
Hernandez-Santiago V; Davey PG; Nathwani D; Marwick CA; Guthrie B
PLoS Med; 2019 Jun; 16(6):e1002825. PubMed ID: 31173597
[TBL] [Abstract][Full Text] [Related]
7. The Association of Antibiotic Stewardship With Fluoroquinolone Prescribing in Michigan Hospitals: A Multi-hospital Cohort Study.
Vaughn VM; Gandhi T; Conlon A; Chopra V; Malani AN; Flanders SA
Clin Infect Dis; 2019 Sep; 69(8):1269-1277. PubMed ID: 30759198
[TBL] [Abstract][Full Text] [Related]
8. Improvement of gram-negative susceptibility to fluoroquinolones after implementation of a pre-authorization policy for fluoroquinolone use: A decade-long experience.
Lee RA; Scully MC; Camins BC; Griffin RL; Kunz DF; Moser SA; Hoesley CJ; McCarty TP; Pappas PG
Infect Control Hosp Epidemiol; 2018 Dec; 39(12):1419-1424. PubMed ID: 30296959
[TBL] [Abstract][Full Text] [Related]
9. Association between fluoroquinolone utilization rates and susceptibilities of gram-negative bacilli: Results from an 8-year intervention by an antibiotic stewardship program in an inner-city United States hospital.
Zeana C; Palmieri FE; Gupta V; Ye G; Lao P; Yu K; Kang KS; Schiller L; Purswani M
Sci Prog; 2021; 104(2):368504211011876. PubMed ID: 33908291
[TBL] [Abstract][Full Text] [Related]
10. Effects of control interventions on Clostridium difficile infection in England: an observational study.
Dingle KE; Didelot X; Quan TP; Eyre DW; Stoesser N; Golubchik T; Harding RM; Wilson DJ; Griffiths D; Vaughan A; Finney JM; Wyllie DH; Oakley SJ; Fawley WN; Freeman J; Morris K; Martin J; Howard P; Gorbach S; Goldstein EJC; Citron DM; Hopkins S; Hope R; Johnson AP; Wilcox MH; Peto TEA; Walker AS; Crook DW;
Lancet Infect Dis; 2017 Apr; 17(4):411-421. PubMed ID: 28130063
[TBL] [Abstract][Full Text] [Related]
11. Effects of fluoroquinolone restriction (from 2007 to 2012) on resistance in Enterobacteriaceae: interrupted time-series analysis.
Sarma JB; Marshall B; Cleeve V; Tate D; Oswald T; Woolfrey S
J Hosp Infect; 2015 Sep; 91(1):68-73. PubMed ID: 26122624
[TBL] [Abstract][Full Text] [Related]
12. Changes in antibiotic consumption, AMR and Clostridioides difficile infections in a large tertiary-care center following the implementation of institution-specific guidelines for antimicrobial therapy: A nine-year interrupted time series study.
Schönherr SG; Ranft D; Lippmann N; Lübbert C
PLoS One; 2021; 16(10):e0258690. PubMed ID: 34648594
[TBL] [Abstract][Full Text] [Related]
13. Outpatient fluoroquinolone prescribing patterns before and after US FDA boxed warning.
Bratsman A; Mathias K; Laubscher R; Grigoryan L; Rose S
Pharmacoepidemiol Drug Saf; 2020 Jun; 29(6):701-707. PubMed ID: 32390266
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial susceptibility and molecular typing of toxigenic clinical isolates of Clostridium difficile causing infections in the south of Spain.
Arca-Suárez J; Galán-Sánchez F; Cano-Cano F; García-Santos G; Rodríguez-Iglesias MA
Anaerobe; 2018 Dec; 54():146-150. PubMed ID: 30261271
[TBL] [Abstract][Full Text] [Related]
15. Evaluating the Effectiveness of an Antimicrobial Stewardship Program on Reducing the Incidence Rate of Healthcare-Associated Clostridium difficile Infection: A Non-Randomized, Stepped Wedge, Single-Site, Observational Study.
DiDiodato G; McArthur L
PLoS One; 2016; 11(6):e0157671. PubMed ID: 27309536
[TBL] [Abstract][Full Text] [Related]
16. Penicillin Binding Protein Substitutions Cooccur with Fluoroquinolone Resistance in Epidemic Lineages of Multidrug-Resistant Clostridioides difficile.
Dingle KE; Freeman J; Didelot X; Quan TP; Eyre DW; Swann J; Spittal WD; Clark EV; Jolley KA; Walker AS; Wilcox MH; Crook DW
mBio; 2023 Apr; 14(2):e0024323. PubMed ID: 37017518
[TBL] [Abstract][Full Text] [Related]
17. Effects of an automatic discontinuation of antibiotics policy: A novel approach to antimicrobial stewardship.
Bolten BC; Bradford JL; White BN; Heath GW; Sizemore JM; White CE
Am J Health Syst Pharm; 2019 Sep; 76(Supplement_3):S85-S90. PubMed ID: 31418771
[TBL] [Abstract][Full Text] [Related]
18. Impact of guidelines and enhanced antibiotic stewardship on reducing broad-spectrum antibiotic usage and its effect on incidence of Clostridium difficile infection.
Talpaert MJ; Gopal Rao G; Cooper BS; Wade P
J Antimicrob Chemother; 2011 Sep; 66(9):2168-74. PubMed ID: 21676904
[TBL] [Abstract][Full Text] [Related]
19. Reduction of fluoroquinolone use is associated with a decrease in methicillin-resistant Staphylococcus aureus and fluoroquinolone-resistant Pseudomonas aeruginosa isolation rates: a 10 year study.
Lafaurie M; Porcher R; Donay JL; Touratier S; Molina JM
J Antimicrob Chemother; 2012 Apr; 67(4):1010-5. PubMed ID: 22240401
[TBL] [Abstract][Full Text] [Related]
20. Unnecessary use of fluoroquinolone antibiotics in hospitalized patients.
Werner NL; Hecker MT; Sethi AK; Donskey CJ
BMC Infect Dis; 2011 Jul; 11():187. PubMed ID: 21729289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
